⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for neosar

Every month we try and update this database with for neosar cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Cord Blood Natural Killer (NK) Cells in Leukemia/LymphomaNCT02280525
Leukemia
Lenalidomide
Rituximab
Fludarabine
Cyclophosphamid...
NK Cells
Cytarabine
18 Years - 80 YearsM.D. Anderson Cancer Center
Adoptive Therapy Using Antigen-Specific CD4 T-CellsNCT02210104
Melanoma
Sarcoma
Ipilimumab
Cyclophosphamid...
CD4+ T cells
18 Years - M.D. Anderson Cancer Center
Molecular Triaging of Newly Diagnosed Breast CancerNCT01159236
Breast Cancer
Paclitaxel
Fluorouracil
Doxorubicin
Epirubicin
Cyclophosphamid...
Bevacizumab
18 Years - M.D. Anderson Cancer Center
Randomized Double Cord Blood Transplant StudyNCT00067002
Leukemia, Lymph...
Leukemia, Myelo...
Leukemia, Myelo...
Lymphoma, Non-H...
Expanded alloge...
One Unmanipulat...
Rituxan
Melphalan
Thiotepa
Fludarabine
Cyclophosphamid...
Mesna
Total body irra...
1 Month - 80 YearsM.D. Anderson Cancer Center
Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)NCT00941928
Leukemia
Pediatric Cance...
Epratuzumab
Fludarabine
Cyclophosphamid...
Mesna
Infusion of NK ...
Interleukin-2
- M.D. Anderson Cancer Center
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)NCT02441803
Leukemia
Busulfan
Fludarabine
Clofarabine
Total Body Irra...
Thymoglobulin
Stem Cell Infus...
Cyclophosphamid...
Tacrolimus
Mycophenolate m...
Decitabine
Cytarabine
Idarubicin
18 Years - 60 YearsM.D. Anderson Cancer Center
Treatment of Tumors of the Choroid Plexus EpitheliumNCT00500890
Choroid Plexus ...
Carboplatin
Cyclophosphamid...
Etoposide
Vincristine
Radiation Thera...
- M.D. Anderson Cancer Center
Fucosylated T Cells for Graft Versus Host Disease (GVHD) PreventionNCT02423915
Leukemia
Lymphoma
Rituximab
Fludarabine
Cyclophosphamid...
Total Body Radi...
Fucosylated Reg...
Cord Blood Infu...
Mycophenolate m...
Sirolimus
Bone Marrow Asp...
G-CSF
Non-Fucosylated...
18 Years - 80 YearsM.D. Anderson Cancer Center
Safety and Efficacy of Campath in Nonmyeloablative TransplantationNCT00038844
Lymphoma
Leukemia
Campath-1 H (Al...
Fludarabine
Cyclophosphamid...
Rituximab
- 70 YearsM.D. Anderson Cancer Center
Primary Breast Cancer Occurring Concomitant With PregnancyNCT00510367
Breast Cancer
Pregnancy
5-Fluorouracil
Cyclophosphamid...
Doxorubicin
- M.D. Anderson Cancer Center
Cord Blood Natural Killer (NK) Cells in Leukemia/LymphomaNCT02280525
Leukemia
Lenalidomide
Rituximab
Fludarabine
Cyclophosphamid...
NK Cells
Cytarabine
18 Years - 80 YearsM.D. Anderson Cancer Center
Autologous Stem Cell Transplants for Chronic Myelogenous LeukemiaNCT00446173
Leukemia
Busulfan
Cyclophosphamid...
G-CSF
GM-CSF
21 Years - 65 YearsM.D. Anderson Cancer Center
Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)NCT01082939
Chronic Lymphoc...
Fludarabine
Cyclophosphamid...
Alemtuzumab
Rituximab
- M.D. Anderson Cancer Center
Autologous Transplantation for Chronic Myelogenous LeukemiaNCT01003054
Chronic Myeloge...
Busulfan
Cyclophosphamid...
Imatinib Mesyla...
Autologous Stem...
- 70 YearsM.D. Anderson Cancer Center
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)NCT01253460
Leukemia
Cyclophosphamid...
Rituximab
Sapacitabine
18 Years - M.D. Anderson Cancer Center
Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid MalignanciesNCT00048737
Lymphoma
Leukemia
Zevalin Radioim...
Rituximab
Fludarabine
Cyclophosphamid...
Allogeneic Stem...
18 Years - 70 YearsM.D. Anderson Cancer Center
Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaNCT00002844
Leukemia
Cyclophosphamid...
Allogeneic Bone...
Autologous Bone...
Total Body Irra...
16 Years - 65 YearsM.D. Anderson Cancer Center
SAHA + CHOP in Untreated T-cell Non-Hodgkin's LymphomaNCT00787527
Lymphoma
Zolinza (vorino...
Cyclophosphamid...
Doxorubicin
Vincristine
Prednisone
18 Years - M.D. Anderson Cancer Center
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk MalignanciesNCT00857389
Stem Cell Trans...
Leukemia
Lymphoma
Thiotepa
Clofarabine
Busulfan
Allogeneic Stem...
Thymoglobulin (...
G-CSF (Filgrast...
Tacrolimus
Methotrexate
Cyclophosphamid...
Mesna
- 60 YearsM.D. Anderson Cancer Center
Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic LeukemiaNCT00002844
Leukemia
Cyclophosphamid...
Allogeneic Bone...
Autologous Bone...
Total Body Irra...
16 Years - 65 YearsM.D. Anderson Cancer Center
Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory NeuroblastomaNCT00698009
Neuroblastoma
Fludarabine
Cyclophosphamid...
Natural Killer ...
Mesna
Interleukin-2
- M.D. Anderson Cancer Center
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast CancerNCT00038402
Breast Cancer
Herceptin
Taxol
Fluorouracil
Cytoxan
Epirubicin
- M.D. Anderson Cancer Center
Safety and Efficacy of Campath in Nonmyeloablative TransplantationNCT00038844
Lymphoma
Leukemia
Campath-1 H (Al...
Fludarabine
Cyclophosphamid...
Rituximab
- 70 YearsM.D. Anderson Cancer Center
Fucosylated T Cells for Graft Versus Host Disease (GVHD) PreventionNCT02423915
Leukemia
Lymphoma
Rituximab
Fludarabine
Cyclophosphamid...
Total Body Radi...
Fucosylated Reg...
Cord Blood Infu...
Mycophenolate m...
Sirolimus
Bone Marrow Asp...
G-CSF
Non-Fucosylated...
18 Years - 80 YearsM.D. Anderson Cancer Center
Adoptive Therapy Using Antigen-Specific CD4 T-CellsNCT02210104
Melanoma
Sarcoma
Ipilimumab
Cyclophosphamid...
CD4+ T cells
18 Years - M.D. Anderson Cancer Center
Study of Bortezomib in Combination With Cyclophosphamide and RituximabNCT00958256
Mantle Cell Lym...
Lymphoma
Bortezomib
Rituximab
Cyclophosphamid...
Mesna
G-CSF
18 Years - 85 YearsM.D. Anderson Cancer Center
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast CancerNCT00429182
Breast Cancer
Metastatic Brea...
Invasive Breast...
Carboplatin
Cyclophosphamid...
Thiotepa
Stem Cell Trans...
18 Years - 55 YearsM.D. Anderson Cancer Center
Autologous Transplantation for Chronic Myelogenous LeukemiaNCT01003054
Chronic Myeloge...
Busulfan
Cyclophosphamid...
Imatinib Mesyla...
Autologous Stem...
- 70 YearsM.D. Anderson Cancer Center
TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple MyelomaNCT01039025
Myeloma
Topotecan
Cyclophosphamid...
Melphalan
Peripheral Bloo...
- 70 YearsM.D. Anderson Cancer Center
Adoptive Therapy Using Antigen-Specific CD4 T-CellsNCT02210104
Melanoma
Sarcoma
Ipilimumab
Cyclophosphamid...
CD4+ T cells
18 Years - M.D. Anderson Cancer Center
Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lymphomas in Patients 60 Years Old or YoungerNCT00290498
Lymphoma
Rituximab
Cyclophosphamid...
Doxorubicin
Vincristine
Dexamethasone
Methotrexate
Cytarabine
Prednisone
16 Years - 60 YearsM.D. Anderson Cancer Center
Cord Blood Natural Killer (NK) Cells in Leukemia/LymphomaNCT02280525
Leukemia
Lenalidomide
Rituximab
Fludarabine
Cyclophosphamid...
NK Cells
Cytarabine
18 Years - 80 YearsM.D. Anderson Cancer Center
Safety and Efficacy of Campath in Nonmyeloablative TransplantationNCT00038844
Lymphoma
Leukemia
Campath-1 H (Al...
Fludarabine
Cyclophosphamid...
Rituximab
- 70 YearsM.D. Anderson Cancer Center
Non-Myeloablative Allogeneic Stem Cell TransplantationNCT00525876
Lymphoma
Cyclophosphamid...
Fludarabine
Rituximab
Alemtuzumab
Allogeneic Stem...
- 70 YearsM.D. Anderson Cancer Center
Treatment of Tumors of the Choroid Plexus EpitheliumNCT00500890
Choroid Plexus ...
Carboplatin
Cyclophosphamid...
Etoposide
Vincristine
Radiation Thera...
- M.D. Anderson Cancer Center
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)NCT02441803
Leukemia
Busulfan
Fludarabine
Clofarabine
Total Body Irra...
Thymoglobulin
Stem Cell Infus...
Cyclophosphamid...
Tacrolimus
Mycophenolate m...
Decitabine
Cytarabine
Idarubicin
18 Years - 60 YearsM.D. Anderson Cancer Center
Molecular Triaging of Newly Diagnosed Breast CancerNCT01159236
Breast Cancer
Paclitaxel
Fluorouracil
Doxorubicin
Epirubicin
Cyclophosphamid...
Bevacizumab
18 Years - M.D. Anderson Cancer Center
Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2NCT01593020
Breast Cancer
Paclitaxel
Eribulin
5-Fluorouracil
Epirubicin
Cyclophosphamid...
Doxorubicin
18 Years - M.D. Anderson Cancer Center
Primary Breast Cancer Occurring Concomitant With PregnancyNCT00510367
Breast Cancer
Pregnancy
5-Fluorouracil
Cyclophosphamid...
Doxorubicin
- M.D. Anderson Cancer Center
Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T CellsNCT01362452
Leukemia
Lymphoma
T-Cell Infusion
Cord Blood Infu...
1 Year - 75 YearsM.D. Anderson Cancer Center
Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic MelanomaNCT00338377
Melanoma
Dendritic Cell ...
Cyclophosphamid...
Fludarabine
T-Cells
Interleukin-2
Mesna
Intrathecal T-C...
Intrathecal Int...
12 Years - M.D. Anderson Cancer Center
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaNCT02419469
Leukemia
Precursor-B Acu...
Lymphoblastic L...
Lymphoma
Cytarabine
Daunorubicin
Vincristine
Prednisone
PEG asparaginas...
Ofatumumab
Rituximab
Methotrexate
Cyclophosphamid...
Mercaptopurine
Doxorubicin
Dexamethasone a...
Thioguanine
12 Years - 30 YearsM.D. Anderson Cancer Center
Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and RituximabNCT00667329
Lymphoma
2CdA
Cyclophosphamid...
Rituximab
- M.D. Anderson Cancer Center
Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and RituximabNCT00667329
Lymphoma
2CdA
Cyclophosphamid...
Rituximab
- M.D. Anderson Cancer Center
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk MalignanciesNCT00857389
Stem Cell Trans...
Leukemia
Lymphoma
Thiotepa
Clofarabine
Busulfan
Allogeneic Stem...
Thymoglobulin (...
G-CSF (Filgrast...
Tacrolimus
Methotrexate
Cyclophosphamid...
Mesna
- 60 YearsM.D. Anderson Cancer Center
Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)NCT01082939
Chronic Lymphoc...
Fludarabine
Cyclophosphamid...
Alemtuzumab
Rituximab
- M.D. Anderson Cancer Center
Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaNCT02419469
Leukemia
Precursor-B Acu...
Lymphoblastic L...
Lymphoma
Cytarabine
Daunorubicin
Vincristine
Prednisone
PEG asparaginas...
Ofatumumab
Rituximab
Methotrexate
Cyclophosphamid...
Mercaptopurine
Doxorubicin
Dexamethasone a...
Thioguanine
12 Years - 30 YearsM.D. Anderson Cancer Center
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast CancerNCT01036087
Breast Cancer
Panitumumab
Nab-paclitaxel
Carboplatin
5-Fluorouracil
Epirubicin
Cyclophosphamid...
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: